July 20th, 2026
Sarcopenia is the name given to later, more severe stages of the characteristic loss of muscle mass and strength that takes place with age. The loss is universal, ultimately leading to physical frailty. Since muscle is metabolically active, loss of muscle is also disruptive to overall metabolism, worsening insulin resistance and chronic inflammation. Like many aspects of degenerative aging, the underlying causes of sarcopenia form a web of interacting mechanisms. It is challenging to determine their relative importance, as well as which mechanisms are largely upstream versus largely downstream in the chain of cause and effect. As is usual, tracing a direct path from root causes of aging to proximate causes of disease is a work in progress, and very incomplete. Most research effort focuses on the proximate causes.
For sarcopenia, the most plausibly important and well studied proximate causes are (a) loss of muscle stem cell activity, reducing the supply of new muscle cells needed to replace losses, and (b) degeneration of the neuromuscular junctions that link the nervous system to muscle fibers. Without innervation, muscle lacks the signaling needed to provoke normal maintenance and growth in response to use. These proximate causes are of course far downstream of issues closer to the roots of aging, such as mitochondrial dysfunction, epigenetic change, senescent cell accumulation, and so forth.
